PMC:7205724 / 17512-18008 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"613","span":{"begin":72,"end":77},"obj":"Species"},{"id":"614","span":{"begin":262,"end":276},"obj":"Species"},{"id":"615","span":{"begin":323,"end":344},"obj":"Species"},{"id":"616","span":{"begin":357,"end":376},"obj":"Species"},{"id":"617","span":{"begin":378,"end":404},"obj":"Species"},{"id":"618","span":{"begin":133,"end":153},"obj":"Disease"},{"id":"619","span":{"begin":157,"end":186},"obj":"Disease"},{"id":"620","span":{"begin":254,"end":260},"obj":"Disease"},{"id":"621","span":{"begin":277,"end":286},"obj":"Disease"},{"id":"622","span":{"begin":298,"end":316},"obj":"Disease"},{"id":"623","span":{"begin":345,"end":355},"obj":"Disease"},{"id":"624","span":{"begin":410,"end":429},"obj":"Disease"},{"id":"625","span":{"begin":445,"end":455},"obj":"Disease"}],"attributes":[{"id":"A613","pred":"tao:has_database_id","subj":"613","obj":"Tax:9606"},{"id":"A614","pred":"tao:has_database_id","subj":"614","obj":"Tax:10798"},{"id":"A615","pred":"tao:has_database_id","subj":"615","obj":"Tax:1496"},{"id":"A616","pred":"tao:has_database_id","subj":"616","obj":"Tax:1764"},{"id":"A617","pred":"tao:has_database_id","subj":"617","obj":"Tax:1773"},{"id":"A618","pred":"tao:has_database_id","subj":"618","obj":"MESH:D001327"},{"id":"A619","pred":"tao:has_database_id","subj":"619","obj":"MESH:D000081207"},{"id":"A620","pred":"tao:has_database_id","subj":"620","obj":"MESH:D018805"},{"id":"A621","pred":"tao:has_database_id","subj":"621","obj":"MESH:D007239"},{"id":"A622","pred":"tao:has_database_id","subj":"622","obj":"MESH:D004660"},{"id":"A623","pred":"tao:has_database_id","subj":"623","obj":"MESH:D007239"},{"id":"A624","pred":"tao:has_database_id","subj":"624","obj":"MESH:D009617"},{"id":"A625","pred":"tao:has_database_id","subj":"625","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T135","span":{"begin":165,"end":173},"obj":"Body_part"},{"id":"T136","span":{"begin":318,"end":321},"obj":"Body_part"}],"attributes":[{"id":"A135","pred":"fma_id","subj":"T135","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A136","pred":"fma_id","subj":"T136","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T123","span":{"begin":133,"end":153},"obj":"Disease"},{"id":"T124","span":{"begin":157,"end":186},"obj":"Disease"},{"id":"T125","span":{"begin":277,"end":286},"obj":"Disease"},{"id":"T126","span":{"begin":298,"end":316},"obj":"Disease"},{"id":"T127","span":{"begin":304,"end":316},"obj":"Disease"},{"id":"T128","span":{"begin":323,"end":355},"obj":"Disease"},{"id":"T129","span":{"begin":392,"end":404},"obj":"Disease"},{"id":"T130","span":{"begin":410,"end":429},"obj":"Disease"},{"id":"T131","span":{"begin":445,"end":458},"obj":"Disease"},{"id":"T132","span":{"begin":459,"end":490},"obj":"Disease"}],"attributes":[{"id":"A123","pred":"mondo_id","subj":"T123","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A124","pred":"mondo_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/MONDO_0015517"},{"id":"A125","pred":"mondo_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0006009"},{"id":"A127","pred":"mondo_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A128","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0000705"},{"id":"A129","pred":"mondo_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/MONDO_0018076"},{"id":"A130","pred":"mondo_id","subj":"T130","obj":"http://purl.obolibrary.org/obo/MONDO_0017776"},{"id":"A131","pred":"mondo_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A132","pred":"mondo_id","subj":"T132","obj":"http://purl.obolibrary.org/obo/MONDO_0015517"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T219","span":{"begin":59,"end":60},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T220","span":{"begin":72,"end":77},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T221","span":{"begin":199,"end":202},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T222","span":{"begin":273,"end":276},"obj":"http://purl.obolibrary.org/obo/CLO_0001798"},{"id":"T223","span":{"begin":298,"end":303},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T70","span":{"begin":78,"end":86},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"},{"id":"T71","span":{"begin":144,"end":153},"obj":"http://purl.obolibrary.org/obo/OGMS_0000045"},{"id":"T72","span":{"begin":254,"end":260},"obj":"http://purl.obolibrary.org/obo/IDO_0000636"},{"id":"T73","span":{"begin":277,"end":286},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"},{"id":"T74","span":{"begin":298,"end":303},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T75","span":{"begin":345,"end":355},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"},{"id":"T76","span":{"begin":419,"end":429},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"},{"id":"T77","span":{"begin":445,"end":458},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T166","span":{"begin":72,"end":77},"obj":"Species"},{"id":"T167","span":{"begin":254,"end":260},"obj":"Species"},{"id":"T168","span":{"begin":262,"end":276},"obj":"Species"},{"id":"T169","span":{"begin":288,"end":303},"obj":"Species"},{"id":"T170","span":{"begin":318,"end":321},"obj":"Species"},{"id":"T175","span":{"begin":323,"end":344},"obj":"Species"},{"id":"T176","span":{"begin":357,"end":376},"obj":"Species"},{"id":"T177","span":{"begin":378,"end":404},"obj":"Species"},{"id":"T178","span":{"begin":410,"end":418},"obj":"Species"}],"attributes":[{"id":"A170","pred":"ncbi_taxonomy_id","subj":"T170","obj":"NCBItxid:57667"},{"id":"A171","pred":"ncbi_taxonomy_id","subj":"T170","obj":"NCBItxid:35274"},{"id":"A172","pred":"ncbi_taxonomy_id","subj":"T170","obj":"NCBItxid:12721"},{"id":"A173","pred":"ncbi_taxonomy_id","subj":"T170","obj":"NCBItxid:11709"},{"id":"A174","pred":"ncbi_taxonomy_id","subj":"T170","obj":"NCBItxid:11676"},{"id":"A177","pred":"ncbi_taxonomy_id","subj":"T177","obj":"NCBItxid:1773"},{"id":"A175","pred":"ncbi_taxonomy_id","subj":"T175","obj":"NCBItxid:1496"},{"id":"A176","pred":"ncbi_taxonomy_id","subj":"T176","obj":"NCBItxid:1764"},{"id":"A168","pred":"ncbi_taxonomy_id","subj":"T168","obj":"NCBItxid:10798"},{"id":"A178","pred":"ncbi_taxonomy_id","subj":"T178","obj":"NCBItxid:1817"},{"id":"A169","pred":"ncbi_taxonomy_id","subj":"T169","obj":"NCBItxid:11082"},{"id":"A166","pred":"ncbi_taxonomy_id","subj":"T166","obj":"NCBItxid:9606"},{"id":"A167","pred":"ncbi_taxonomy_id","subj":"T167","obj":"NCBItxid:137507"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T143","span":{"begin":0,"end":187},"obj":"Sentence"},{"id":"T144","span":{"begin":188,"end":496},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"613","span":{"begin":72,"end":77},"obj":"Species"},{"id":"618","span":{"begin":133,"end":153},"obj":"Disease"},{"id":"619","span":{"begin":157,"end":186},"obj":"Disease"},{"id":"620","span":{"begin":254,"end":260},"obj":"Disease"},{"id":"614","span":{"begin":262,"end":276},"obj":"Species"},{"id":"621","span":{"begin":277,"end":286},"obj":"Disease"},{"id":"622","span":{"begin":298,"end":316},"obj":"Disease"},{"id":"615","span":{"begin":323,"end":344},"obj":"Species"},{"id":"623","span":{"begin":345,"end":355},"obj":"Disease"},{"id":"616","span":{"begin":357,"end":376},"obj":"Species"},{"id":"617","span":{"begin":378,"end":404},"obj":"Species"},{"id":"624","span":{"begin":410,"end":429},"obj":"Disease"},{"id":"625","span":{"begin":445,"end":455},"obj":"Disease"}],"attributes":[{"id":"A615","pred":"pubann:denotes","subj":"615","obj":"Tax:1496"},{"id":"A620","pred":"pubann:denotes","subj":"620","obj":"MESH:D018805"},{"id":"A618","pred":"pubann:denotes","subj":"618","obj":"MESH:D001327"},{"id":"A624","pred":"pubann:denotes","subj":"624","obj":"MESH:D009617"},{"id":"A622","pred":"pubann:denotes","subj":"622","obj":"MESH:D004660"},{"id":"A613","pred":"pubann:denotes","subj":"613","obj":"Tax:9606"},{"id":"A617","pred":"pubann:denotes","subj":"617","obj":"Tax:1773"},{"id":"A616","pred":"pubann:denotes","subj":"616","obj":"Tax:1764"},{"id":"A621","pred":"pubann:denotes","subj":"621","obj":"MESH:D007239"},{"id":"A623","pred":"pubann:denotes","subj":"623","obj":"MESH:D007239"},{"id":"A619","pred":"pubann:denotes","subj":"619","obj":"MESH:D000081207"},{"id":"A625","pred":"pubann:denotes","subj":"625","obj":"MESH:D007239"},{"id":"A614","pred":"pubann:denotes","subj":"614","obj":"Tax:10798"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T1970","span":{"begin":273,"end":276},"obj":"Protein"}],"attributes":[{"id":"A1970","pred":"uniprot_id","subj":"T1970","obj":"https://www.uniprot.org/uniprot/P57058"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T12037","span":{"begin":0,"end":4},"obj":"NN"},{"id":"T52317","span":{"begin":5,"end":7},"obj":"VBZ"},{"id":"T83276","span":{"begin":8,"end":10},"obj":"DT"},{"id":"T47689","span":{"begin":11,"end":27},"obj":"JJ"},{"id":"T32201","span":{"begin":28,"end":37},"obj":"NN"},{"id":"T26744","span":{"begin":38,"end":47},"obj":"RB"},{"id":"T6595","span":{"begin":48,"end":54},"obj":"JJ"},{"id":"T61951","span":{"begin":55,"end":58},"obj":"IN"},{"id":"T78252","span":{"begin":59,"end":60},"obj":"DT"},{"id":"T96672","span":{"begin":61,"end":68},"obj":"NN"},{"id":"T75647","span":{"begin":69,"end":71},"obj":"IN"},{"id":"T64366","span":{"begin":72,"end":77},"obj":"JJ"},{"id":"T37666","span":{"begin":78,"end":86},"obj":"NNS"},{"id":"T30663","span":{"begin":87,"end":91},"obj":"WDT"},{"id":"T71611","span":{"begin":92,"end":97},"obj":"VBP"},{"id":"T4369","span":{"begin":98,"end":100},"obj":"DT"},{"id":"T95969","span":{"begin":101,"end":111},"obj":"JJ"},{"id":"T35011","span":{"begin":112,"end":118},"obj":"NN"},{"id":"T94518","span":{"begin":118,"end":119},"obj":"-COMMA-"},{"id":"T34533","span":{"begin":120,"end":127},"obj":"VBG"},{"id":"T57537","span":{"begin":128,"end":132},"obj":"IN"},{"id":"T47481","span":{"begin":133,"end":143},"obj":"JJ"},{"id":"T10634","span":{"begin":144,"end":153},"obj":"NNS"},{"id":"T96539","span":{"begin":154,"end":156},"obj":"TO"},{"id":"T18270","span":{"begin":157,"end":164},"obj":"JJ"},{"id":"T92790","span":{"begin":165,"end":173},"obj":"NN"},{"id":"T91348","span":{"begin":174,"end":186},"obj":"NNS"},{"id":"T23275","span":{"begin":188,"end":192},"obj":"RB"},{"id":"T97483","span":{"begin":192,"end":193},"obj":"-COMMA-"},{"id":"T12179","span":{"begin":194,"end":198},"obj":"NNP"},{"id":"T44219","span":{"begin":199,"end":202},"obj":"VBZ"},{"id":"T10629","span":{"begin":203,"end":208},"obj":"VBN"},{"id":"T45168","span":{"begin":209,"end":218},"obj":"JJ"},{"id":"T67208","span":{"begin":219,"end":226},"obj":"NNS"},{"id":"T77083","span":{"begin":227,"end":229},"obj":"IN"},{"id":"T72909","span":{"begin":230,"end":234},"obj":"NN"},{"id":"T84121","span":{"begin":235,"end":237},"obj":"IN"},{"id":"T92712","span":{"begin":238,"end":244},"obj":"JJ"},{"id":"T79863","span":{"begin":245,"end":246},"obj":"-LRB-"},{"id":"T66824","span":{"begin":246,"end":250},"obj":"JJ"},{"id":"T43956","span":{"begin":251,"end":253},"obj":"IN"},{"id":"T9832","span":{"begin":254,"end":260},"obj":"NN"},{"id":"T13628","span":{"begin":260,"end":261},"obj":"-COMMA-"},{"id":"T62406","span":{"begin":262,"end":272},"obj":"NN"},{"id":"T99835","span":{"begin":273,"end":276},"obj":"NN"},{"id":"T14835","span":{"begin":277,"end":286},"obj":"NN"},{"id":"T15497","span":{"begin":286,"end":287},"obj":"-COMMA-"},{"id":"T90831","span":{"begin":288,"end":292},"obj":"NNP"},{"id":"T76795","span":{"begin":293,"end":297},"obj":"NNP"},{"id":"T72325","span":{"begin":298,"end":303},"obj":"NN"},{"id":"T62294","span":{"begin":304,"end":316},"obj":"NN"},{"id":"T79163","span":{"begin":316,"end":317},"obj":"-COMMA-"},{"id":"T42313","span":{"begin":318,"end":321},"obj":"NN"},{"id":"T73958","span":{"begin":321,"end":322},"obj":"-COMMA-"},{"id":"T29310","span":{"begin":323,"end":334},"obj":"NNP"},{"id":"T49447","span":{"begin":335,"end":344},"obj":"JJ"},{"id":"T8038","span":{"begin":345,"end":355},"obj":"NNS"},{"id":"T10219","span":{"begin":355,"end":356},"obj":"-COMMA-"},{"id":"T3443","span":{"begin":357,"end":370},"obj":"NN"},{"id":"T55185","span":{"begin":371,"end":376},"obj":"NN"},{"id":"T2677","span":{"begin":376,"end":377},"obj":"-COMMA-"},{"id":"T67405","span":{"begin":378,"end":391},"obj":"NN"},{"id":"T65630","span":{"begin":392,"end":404},"obj":"NN"},{"id":"T60726","span":{"begin":404,"end":405},"obj":"-COMMA-"},{"id":"T52785","span":{"begin":406,"end":409},"obj":"CC"},{"id":"T44446","span":{"begin":410,"end":418},"obj":"NNP"},{"id":"T90848","span":{"begin":419,"end":429},"obj":"NNS"},{"id":"T80386","span":{"begin":429,"end":430},"obj":"-RRB-"},{"id":"T6178","span":{"begin":431,"end":434},"obj":"CC"},{"id":"T68317","span":{"begin":435,"end":444},"obj":"JJ"},{"id":"T17705","span":{"begin":445,"end":455},"obj":"NNS"},{"id":"T68999","span":{"begin":456,"end":458},"obj":"IN"},{"id":"T18422","span":{"begin":459,"end":466},"obj":"JJ"},{"id":"T52471","span":{"begin":467,"end":477},"obj":"NNS"},{"id":"T62247","span":{"begin":478,"end":490},"obj":"NNS"},{"id":"T55724","span":{"begin":491,"end":492},"obj":"-LRB-"},{"id":"T27007","span":{"begin":492,"end":494},"obj":"CD"},{"id":"T97422","span":{"begin":494,"end":495},"obj":"-RRB-"}],"relations":[{"id":"R7397","pred":"arg1Of","subj":"T12037","obj":"T52317"},{"id":"R59827","pred":"arg2Of","subj":"T32201","obj":"T52317"},{"id":"R45922","pred":"arg1Of","subj":"T32201","obj":"T83276"},{"id":"R32666","pred":"arg1Of","subj":"T32201","obj":"T47689"},{"id":"R38821","pred":"arg1Of","subj":"T32201","obj":"T26744"},{"id":"R80185","pred":"arg1Of","subj":"T26744","obj":"T6595"},{"id":"R62385","pred":"arg1Of","subj":"T6595","obj":"T61951"},{"id":"R78431","pred":"arg2Of","subj":"T96672","obj":"T61951"},{"id":"R3964","pred":"arg1Of","subj":"T96672","obj":"T78252"},{"id":"R72167","pred":"arg1Of","subj":"T96672","obj":"T75647"},{"id":"R82814","pred":"arg2Of","subj":"T37666","obj":"T75647"},{"id":"R55274","pred":"arg1Of","subj":"T37666","obj":"T64366"},{"id":"R31515","pred":"arg1Of","subj":"T37666","obj":"T30663"},{"id":"R12726","pred":"arg1Of","subj":"T37666","obj":"T71611"},{"id":"R20851","pred":"arg2Of","subj":"T35011","obj":"T71611"},{"id":"R86274","pred":"arg1Of","subj":"T35011","obj":"T4369"},{"id":"R95215","pred":"arg1Of","subj":"T35011","obj":"T95969"},{"id":"R10701","pred":"arg1Of","subj":"T32201","obj":"T94518"},{"id":"R19665","pred":"arg1Of","subj":"T32201","obj":"T34533"},{"id":"R89530","pred":"arg1Of","subj":"T34533","obj":"T57537"},{"id":"R77337","pred":"arg2Of","subj":"T10634","obj":"T57537"},{"id":"R63281","pred":"arg1Of","subj":"T10634","obj":"T47481"},{"id":"R45693","pred":"arg1Of","subj":"T34533","obj":"T96539"},{"id":"R65268","pred":"arg2Of","subj":"T91348","obj":"T96539"},{"id":"R94792","pred":"arg1Of","subj":"T91348","obj":"T18270"},{"id":"R91107","pred":"arg1Of","subj":"T91348","obj":"T92790"},{"id":"R9941","pred":"arg1Of","subj":"T10629","obj":"T23275"},{"id":"R28227","pred":"arg1Of","subj":"T10629","obj":"T97483"},{"id":"R92669","pred":"arg1Of","subj":"T12179","obj":"T44219"},{"id":"R31307","pred":"arg2Of","subj":"T10629","obj":"T44219"},{"id":"R77637","pred":"arg1Of","subj":"T12179","obj":"T10629"},{"id":"R23512","pred":"arg2Of","subj":"T67208","obj":"T10629"},{"id":"R8504","pred":"arg1Of","subj":"T67208","obj":"T45168"},{"id":"R20697","pred":"arg1Of","subj":"T67208","obj":"T77083"},{"id":"R78894","pred":"arg2Of","subj":"T72909","obj":"T77083"},{"id":"R82064","pred":"arg1Of","subj":"T72909","obj":"T84121"},{"id":"R98709","pred":"arg2Of","subj":"T6178","obj":"T84121"},{"id":"R28624","pred":"arg1Of","subj":"T52785","obj":"T92712"},{"id":"R80380","pred":"arg2Of","subj":"T52785","obj":"T79863"},{"id":"R24626","pred":"arg3Of","subj":"T80386","obj":"T79863"},{"id":"R19944","pred":"arg1Of","subj":"T43956","obj":"T66824"},{"id":"R49580","pred":"arg1Of","subj":"T52785","obj":"T43956"},{"id":"R37840","pred":"arg2Of","subj":"T13628","obj":"T43956"},{"id":"R28995","pred":"arg1Of","subj":"T9832","obj":"T13628"},{"id":"R16863","pred":"arg2Of","subj":"T14835","obj":"T13628"},{"id":"R40263","pred":"arg1Of","subj":"T14835","obj":"T62406"},{"id":"R95673","pred":"arg1Of","subj":"T14835","obj":"T99835"},{"id":"R52070","pred":"arg1Of","subj":"T13628","obj":"T15497"},{"id":"R13275","pred":"arg2Of","subj":"T62294","obj":"T15497"},{"id":"R22619","pred":"arg1Of","subj":"T76795","obj":"T90831"},{"id":"R23224","pred":"arg1Of","subj":"T62294","obj":"T76795"},{"id":"R99263","pred":"arg1Of","subj":"T62294","obj":"T72325"},{"id":"R15788","pred":"arg1Of","subj":"T62294","obj":"T79163"},{"id":"R54321","pred":"arg2Of","subj":"T42313","obj":"T79163"},{"id":"R99309","pred":"arg1Of","subj":"T52785","obj":"T73958"},{"id":"R85642","pred":"arg1Of","subj":"T8038","obj":"T29310"},{"id":"R55554","pred":"arg1Of","subj":"T8038","obj":"T49447"},{"id":"R94197","pred":"arg1Of","subj":"T8038","obj":"T10219"},{"id":"R30216","pred":"arg2Of","subj":"T55185","obj":"T10219"},{"id":"R46944","pred":"arg1Of","subj":"T55185","obj":"T3443"},{"id":"R36023","pred":"arg1Of","subj":"T10219","obj":"T2677"},{"id":"R30475","pred":"arg2Of","subj":"T65630","obj":"T2677"},{"id":"R32473","pred":"arg1Of","subj":"T65630","obj":"T67405"},{"id":"R79700","pred":"arg1Of","subj":"T52785","obj":"T60726"},{"id":"R5424","pred":"arg1Of","subj":"T2677","obj":"T52785"},{"id":"R82963","pred":"arg2Of","subj":"T90848","obj":"T52785"},{"id":"R12367","pred":"arg1Of","subj":"T90848","obj":"T44446"},{"id":"R36176","pred":"arg1Of","subj":"T52785","obj":"T6178"},{"id":"R5432","pred":"arg2Of","subj":"T17705","obj":"T6178"},{"id":"R7624","pred":"arg1Of","subj":"T17705","obj":"T68317"},{"id":"R48790","pred":"arg1Of","subj":"T6178","obj":"T68999"},{"id":"R33893","pred":"arg2Of","subj":"T62247","obj":"T68999"},{"id":"R41252","pred":"arg1Of","subj":"T62247","obj":"T18422"},{"id":"R34450","pred":"arg1Of","subj":"T62247","obj":"T52471"},{"id":"R24969","pred":"arg1Of","subj":"T62247","obj":"T55724"},{"id":"R29860","pred":"arg2Of","subj":"T27007","obj":"T55724"},{"id":"R45347","pred":"arg3Of","subj":"T97422","obj":"T55724"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T135","span":{"begin":165,"end":173},"obj":"Body_part"},{"id":"T136","span":{"begin":318,"end":321},"obj":"Body_part"}],"attributes":[{"id":"A135","pred":"fma_id","subj":"T135","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A136","pred":"fma_id","subj":"T136","obj":"http://purl.org/sig/ont/fma/fma278683"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T119","span":{"begin":133,"end":153},"obj":"Disease"},{"id":"T120","span":{"begin":157,"end":186},"obj":"Disease"},{"id":"T121","span":{"begin":277,"end":286},"obj":"Disease"},{"id":"T122","span":{"begin":298,"end":316},"obj":"Disease"},{"id":"T123","span":{"begin":323,"end":355},"obj":"Disease"},{"id":"T124","span":{"begin":392,"end":404},"obj":"Disease"},{"id":"T125","span":{"begin":410,"end":429},"obj":"Disease"},{"id":"T126","span":{"begin":445,"end":458},"obj":"Disease"},{"id":"T127","span":{"begin":459,"end":490},"obj":"Disease"}],"attributes":[{"id":"A122","pred":"mondo_id","subj":"T122","obj":"http://purl.obolibrary.org/obo/MONDO_0006009"},{"id":"A119","pred":"mondo_id","subj":"T119","obj":"http://purl.obolibrary.org/obo/MONDO_0007179"},{"id":"A121","pred":"mondo_id","subj":"T121","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A127","pred":"mondo_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/MONDO_0015517"},{"id":"A120","pred":"mondo_id","subj":"T120","obj":"http://purl.obolibrary.org/obo/MONDO_0015517"},{"id":"A123","pred":"mondo_id","subj":"T123","obj":"http://purl.obolibrary.org/obo/MONDO_0000705"},{"id":"A124","pred":"mondo_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/MONDO_0018076"},{"id":"A126","pred":"mondo_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A125","pred":"mondo_id","subj":"T125","obj":"http://purl.obolibrary.org/obo/MONDO_0017776"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T4","span":{"begin":133,"end":153},"obj":"Phenotype"},{"id":"T5","span":{"begin":254,"end":260},"obj":"Phenotype"},{"id":"T6","span":{"begin":304,"end":316},"obj":"Phenotype"},{"id":"T7","span":{"begin":435,"end":455},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0002960"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0100806"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0002383"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0002719"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T143","span":{"begin":0,"end":187},"obj":"Sentence"},{"id":"T144","span":{"begin":188,"end":496},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T4","span":{"begin":133,"end":153},"obj":"Phenotype"},{"id":"T5","span":{"begin":254,"end":260},"obj":"Phenotype"},{"id":"T6","span":{"begin":304,"end":316},"obj":"Phenotype"},{"id":"T7","span":{"begin":435,"end":455},"obj":"Phenotype"}],"attributes":[{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0002960"},{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0100806"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0002383"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0002719"}],"text":"IVIG is an immunomodulatory treatment currently useful for a variety of human diseases that share an idiopathic origin, ranging from autoimmune disorders to primary antibody deficiencies. Also, IVIG has shown promising results in case of severe (such as sepsis, Parvovirus B19 infection, West Nile virus encephalitis, HIV, Clostridium difficile infections, Mycobacterium avium, Mycobacterium tuberculosis, and Nocardia infections) and recurrent infections in primary antibodies deficiencies [21]."}